Ozempic Changed Obesity Treatment Forever — but Experts See a Bigger Medical Revolution Still Coming

Substack 4: Nutrition Researchers Say It’s the Doctors Who Are Fooling Themselves – Are They?

The very controversial history surrounding dietary therapy for obesity and diabetes comes down to one consistent and very obvious conflict. Physicians, like the UK’s David Unwin in his recent article, insist that they know better how to successfully treat their patients than the academic nutritionists and epidemiologists in their Ivy Towers. The physicians have argued...Read More »

Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win

Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win

ELI LILLY gave extraordinary obesity drug access to 79-year-old patient. Who?

ELI LILLY gave extraordinary obesity drug access to 79-year-old patient. Who? (Top headline, 1st story, link) Drudge Report Feed needs your support! Become a Patron

Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health

Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health

Study: Combined medication and lifestyle changes work best for children with obesity

Study: Combined medication and lifestyle changes work best for children with obesity

White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug

Photo Illustration by Elizabeth Brockway/The Daily Beast/GettyA 79-year-old man was given special access to an unreleased Eli Lilly obesity drug in April that was unavailable to the public. At first, those with knowledge of the patient’s identity would not directly deny that the man was President Donald Trump, who turned 80 earlier this month.Stat News reported Tuesday that the drug, called retatrutide, drew the interest of several top health officials, suggesting that the person who obtained it was high up the chain of command.Read more at The Daily Beast.

Study: Lifestyle Interventions Outperform Drugs Alone for Childhood Obesity

(NaturalNews) A new analysis published in JAMA Pediatrics found that behavioral and lifestyle interventions for adolescent obesity significantly reduced body mass i...

The Ozempic Question Nobody Wants To Answer

This article is part of Upstream, The Daily Wire’s new home for culture and lifestyle. Real human insight and human stories — from our featured writers to you. *** Almost a year ago, when my doctor recommended I go on a weight-loss medication, she asked what my goal weight was. After having six babies in nine ...

Akses perlindungan kesihatan digital lebih mudah dengan Kaotim MediKad

KOS rawatan kesihatan yang semakin meningkat ketika ini membuatkan ramai mula memberi perhatian terhadap kepentingan perlindungan perubatan, khusus­nya pelan yang lebih mudah di­akses dan tidak membebankan komitmen bulanan. Seiring perubahan gaya hidup digital, Kaotim MediKad di­per­kenalkan oleh Syarikat Ta­ka­ful Malaysia Keluarga Berhad (Ta­kaful Malaysia) sebagai pilihan perlindungan perubatan yang lebih ringkas, pantas dan mesra pengguna. Pelan ... Read more The post Akses perlindungan kesihatan digital lebih mudah dengan Kaotim MediKad appeared first on Utusan Malaysia.

Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health

Dr. Mehmet Oz backs GLP-1 weight loss medication but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.

One 79-year-old Patient Given Unapproved Powerful Obesity Drug

Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.

America gets supersized as obesity rates spike in both children and adults

Rising obesity rates have been tied to a more sedentary lifestyle and ultraprocessed diet

FDA Reviews Sandoz Generic Obesity Drug Applications

The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.

Diagnostic dilemma: Huge mass in woman's stomach was likely caused by Ozempic-style drug — and dissolved with diet soda

Diagnostic dilemma: Huge mass in woman's stomach was likely caused by Ozempic-style drug — and dissolved with diet soda

Please join us! “Fireside chat” webinar tomorrow with Angiex founders

Dear readers, Please join me Wednesday at 4 pm Eastern with famed scientist, angiogenesis expert, discoverer of VEGF, and Angiex co-founder Dr. Harold Dvorak in an online Fireside Chat. We’ll discuss Hal’s pathbreaking work in angiogenesis; the efforts of Hal Read more » The post Please join us! “Fireside chat” webinar tomorrow with Angiex founders appeared first on Perfect Health Diet.

On the left, actual doctors saying that losing weight isn't just about counting calories. On the right, people angrily pointing pointing at the Second Law of Thermodynamics. And... go [Interesting]

[link] [6 comments]

As Aussie waistlines expand, so do treatment costs

Most adult Australians are actually overweight or obese and that number is rising, research shows, with the problem taking a growing toll on health systems.

Obesity: Free medication program ends as Health Ministry seeks two-month extension

If the extension is not approved, the disruption will affect only July and August, as the entire Prevent program is expected to resume with national funding from September, the Prime Minister announced at the ygeiamou.gr health conference The post Obesity: Free medication program ends as Health Ministry seeks two-month extension appeared first on ProtoThema English.

Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access

Novo Nordisk (CPSE:NOVO B) has received UK regulatory approval for an oral version of Wegovy, making it the first authorized daily GLP-1 pill for weight management in the country. The approval covers obese and overweight adults, providing a meaningful alternative to injectable GLP-1 therapies that have dominated the obesity treatment landscape. The decision is expected [] The post Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access appeared first on Foreign Policy Journal.

Choosing 'fat-free' options, eating right before bed and too much sitting down are among the common midlife mistakes that lead to heart disease

Choosing 'fat-free' options, eating right before bed and too much sitting down are among the common midlife mistakes that lead to heart disease

Statins and Blood Pressure Drugs Are Closing the Heart-Risk Gap Between Obese and Normal-Weight Adults, Study Finds

A Lancet study tracking nearly one million people across seven countries found that obese adults over 60 now show blood pressure and cholesterol profiles nearly identical to normal-weight peers, driven by widespread statin and antihypertensive use. Researchers warn this reflects pharmaceutical management of cardiovascular risk, not safer obesity.

Was it Trump who couldn’t wait for a new weight loss drug?

A 79-year-old US man with weight problems was given priority access to a powerful new injectable treatment in April. Who could it have been?

Joe Manganiello Shares Yearslong Illnesses "Attacked" His Skin & Eyes

Joe Manganiello is looking back at a difficult chapter. The True Blood alum shared a rare glimpse into navigating his nearly decade-long health battle due to autoimmune-related illnesses while in...

July 11 – Heart Fit Clinic

Heart Fit Clinic will be on Talk To The Experts this weekend – Saturday, July 11th at noon! There is never a bad time to examine just where your health truly is. It’s time to contact the Heart Fit Clinic! Ever have those spicy wings and experience a bit of acid reflux, but didn’t think...

Obesity To PCOS: Nutritionist Shares 8 Habits To Avoid For Better Health

In a recent Instagram post, nutritionist Lovneet Batra highlights common mistakes that may worsen health conditions such as obesity, hypothyroidism, fatty liver disease, hair fall, anxiety, bloating,...

The most quietly significant day of the decade is about to arrive

Stefano Hatfield: Weight-loss drugs in pill form will change Britain more than any of us can anticipate

Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!

Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...

Laboratorium. Revolution in nutrition

Laboratorium. Revolution in nutrition

dsm-firmenich awards 2026 Nutrition Research Grant investigating nutrients bio-actives healthy longevity Asia Pacific

dsm-firmenich, innovators in nutrition, health, and beauty, today awarded the second round of the Nutrition Research ...

Alive and Kicking: News of Woke’s Death Is Greatly Exaggerated

RealClearWire—Just a few years ago, wearing a sombrero on Halloween could get you banished from polite society for the social crime of “cultural appropriation.” Nutrition experts argued that preventing obesity was a form of racialized “fatphobia,” even as scientific names of songbirds were purged in a moral campaign presumably aimed at white supremacy. Meanwhile, a slew of studies, papers, and articles argued that punctuality, excellence, and other forms of professionalism are “the systemic, institutionalized centering of whiteness.” Today, as universities are dismantling...

Researchers Found One Type Of Diet That May Promote Excess Weight

Adjusting your diet can make all the difference.

5 Things IV Infusion Therapy Can Do for Your Health

IV infusion therapy has moved well beyond hospital rooms. What was once reserved strictly for

I Live in Portland and My Vitamin D Levels Are a Disaster—Here’s the Fix

A dietitian breaks down why deficiency is so common and what to do about it. The post I Live in Portland and My Vitamin D Levels Are a Disaster—Here’s the Fix appeared first on Camille Styles.

Medicare recipients get obesity drug coverage starting July 1

Millions of older Americans in Medicare are about to gain access to obesity drugs for the first time — but that landmark shift may be flying under the radar for many of them. Starting Wednesday, eligible beneficiaries can get obesity drugs through Medicare’s new Bridge demonstration program for a monthly copay of just 50. The []...Click to read more

Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

Public notice of a single compassionate use case is odd in every way.

Why the secret to losing weight could be a simple tweak to your prescription. If you take medication every day, here's what you must ask your GP

Why the secret to losing weight could be a simple tweak to your prescription. If you take medication every day, here's what you must ask your GP

Japa crisis: Fix healthcare or lose all doctors — Physicians

CONFERENCE of the West African College of Physicians, WACP, yesterday, urged government at all levels to strengthen the health system or risk worsening the ongoing migration of skilled medical professionals... The post Japa crisis: Fix healthcare or lose all doctors — Physicians appeared first on Vanguard News.